An interventional study of Determining of the clinical class of chronic venous disorders by artificial intelligence in Varicose Veins of Lower Limb and Telangiectasia, sponsored by Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia. Completed at 3 sites in Russia. Per ClinicalTrials.gov, last updated 2026-03-06.
Sponsored by Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia · Not applicable, Interventional, and Screening
Purpose: To evaluate the sensitivity and specificity of the method for determining the clinical class of chronic venous diseases using the Ivenus application (within C0-C2 according to CEAP).
Materials and methods: Patients who applied to several phlebology clinics for an initial consultation are consistently included in a multicenter prospective study. At the appointment, a doctor with at least 5 years of experience takes photographs of the lower extremities and uploads them to the IVENUS application, which automatically determines the clinical class according to CEAP, without showing the results to the surgeon (blinding). Further, the doctor independently determines the clinical class according to CEAP and enters the data into the register.
The object of the study is a photograph of a certain area of the lower limb.
69 studies on the registry are indexed under Telangiectasis; 12 are open to participants now.
This study's enrollment of 1,622 is above the median of 30 across 59 interventional studies indexed under Telangiectasis.
Browse Telangiectasis studies →Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The doctor takes pictures of the lower extremities and uploads them to the IVENUS application, which automatically determines the clinical class according to CEAP. Further, the doctor independently determines the clinical class according to CEAP and enters the data into the register.
Determination of the sensitivity and specificity
Determination of the sensitivity and specificity of the method for determining the clinical class of chronic venous diseases according to the CEAP classification using the IVENUS application (within C0-C2 classes).
Time frame: 1 day
Number of participants with complications
Any serious adverse event will be recorded
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2023 to primary completion in Feb 2026, 29 months.
Of 14 interventional studies with no phase under Telangiectasis, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 27. This study's 29 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia